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ABSTRACT
Ticks are obligate haematophagous ectoparasites of wild and domestic animals as well as humans, considered to be second 
worldwide to mosquitoes as vectors of human diseases. Tick-borne diseases are responsible worldwide for great economic losses 
in terms of mortality and morbidity of livestock animals. This review concerns to the different tick and tick-parasites control 
methods having a major focus on vaccines. Control of tick infestations has been mainly based on the use of acaricides, a control 
measure with serious drawbacks, as responsible for the contamination of milk and meat products, as a selective factor for acaricide-
resistant ticks and as an environmental contaminant. Research on alternatives to the use of acaricides is strongly represented by 
tick vaccines considered a more cost-effective and environmentally safe strategy. Vaccines based on the Bm86 tick antigen were 
used in the fi rst commercially available cattle tick vaccines and showed good results in reducing tick numbers, affecting weight 
and reproductive performance of female ticks which resulted in reduction of cattle tick populations over time and consequently 
lower reduction of the pathogen agents they carry.
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TICKS AND TICK-BORNE DISEASES
Ticks are arthropods with a complex life cycle, proven 
resilient and persistent in the environment. Three families 
are currently recognized: Ixodidae (hard ticks), Argasidae 
(soft ticks) and the recently identifi ed Nuttalliellidae1. Hard 
ticks distinguish themselves by the presence of a scutum or hard 
shield that grows to accommodate large volumes of ingested 
blood, which, in adult ticks, reaches 200 to 600 times their unfed 
body weight. On the contrary, soft ticks accommodate smaller 
volumes of blood (5 to10 times their unfed body) and can resist 
to starvation, surviving for long periods of time without a blood 
meal2. The Nuttalliellidae family contains only one species, 
Nuttalliela namaqua, which exhibits intermediate characteristics 
in comparison with the other two1. Adult ticks, larvae or nymphs 
(pre-adult stages) can be infected horizontally by feeding on 
infected vertebrate hosts, or within the ticks, from the female 
to the eggs, maintaining the infection to the hatched larvae, a 
phenomenon denoted as transovarial transmission. There is also 
the transtadial transmission, which is the pathogen’s diffusion 
from one tick life stage through a molt to the next instar3.
These ecto-parasites have direct impact on the vertebrate 
hosts, leading to reduction of body weight, and in cattle, affect 
the milk and meat production, while ticks’ bites reduce the 
quality of leathers. Among domestic animals, they are also 
responsible for anemia and severe dermatitis4-6. Apart from these 
direct effects, the most important feature of ticks is that they 
are vectors, as well as reservoirs, of multiple pathogens. Ticks 
and tick-transmitted parasites have co-evolved with various 
wild animal hosts, being part of the ecosystem’s equilibrium3. 
Tick-borne diseases (TBDs), long known but often neglected, 
are progressively being recognized due to their economic impact 
in livestock, but also due to their impact in human health, to 
which they have become a threat.
Examples of TBDs transmitted to man are Lyme borreliosis 
by Ixodes sp. ticks, caused by at least three species of bacteria 
belonging to the genus Borrelia spp. and Rocky Mountain 
spotted fever, caused by Rickettsia rickettsii spread by 
Dermacentor variabilis. Changes in land use, reforestation, 
human demographics and behavior, are altering the interactions 
between human and infectious disease agents leading to the 
emergence of other infectious and zoonotic diseases7. Under 
these circumstances, arthropod vectors may enhance their 
potential to spread bacteria, viruses, protozoa and helminthes8. 
Nevertheless, the major medical and economic concerns 
with ticks and TBDs remain in the veterinarian fi eld with a 
special emphasis on animal production. TBDs, as theileriosis, 
babesiosis, anaplasmosis and heartwater (also called cowdriosis), 
are considered the most important, concerning both health and 
management problems of cattle and small ruminants, especially 
in Latin America, Africa, Australia and Asia. Economically, the 
most important livestock ticks belong to the family Ixodidae, 
genera Hyalomma spp., Rhipicephalus (Boophilus) spp. and 
Amblyomma spp. Theileriosis and babesiosis are caused by the 
protozoan parasites Theileria parva, T. annulata and Babesia 
bovis or B. bigemina, correspondingly. While the heartwater 
and anaplasmosis are caused by the Rickettsiales, Ehrlichia 
ruminantium and Anaplasma marginale, respectively2,8,9.
CONTROL METHODS
So far, the use of acaricides has been a major component of 
integrated tick control methods. Even before Smith & Kilborne 
(1893) proved the role of ticks as vectors of Babesia spp., animal
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health authorities in the USA, Australia and Southern Africa were 
treating cattle with a variety of chemical agents, mainly mixtures 
of querosene, sulphur and lard, in an effort to control ticks. 
Acaricides are often inappropriately used, have residual effects 
in milk and meat subproducts, and are not environmentally 
friendly, being responsible for the increase of acaricide-resistant 
ticks10,11. Resistance is associated to mutations in genes related 
to drug susceptibility. The appearance of acaricides’ resistance 
leads to the rise of individuals for which the lethal dose is higher 
than the one for the majority of determined specie. Nowadays, 
combinations of powerful acaricides are being used worldwide; 
products combining different active components are available 
in an attempt to include a diverse number of mechanisms of 
action, to reduce the emergence of insecticide resistance12,13.
For companion animals, a formulation combining dinotefuran, 
permethrin and pyriproxyfen (Vectra 3D) was registered in the 
USA in 2007, and is indicated for the prevention and treatment 
of fl eas, ticks, fl ies and mosquitoes, on dogs14,15. Others like 
imidacloprid/fl umethrin collar [Seresto®, Bayer Animal Health, 
Investigational Veterinary Product (IVP)], a deltamethrin collar 
(Scalibor®, MSD, CP1), a fipronil/(s)-methoprene spot-on 
(Frontline Combo®, Merial, CP2), and an amitraz/fi pronil/
(s)-methoprene spot-on (Certifect®, Merial, CP4/CP5) against 
repeated infestations with Rhipicephalus sanguineus and 
Ctenocephalides felis felis are being tested for effi cacy15. The 
example of pet animals is not valid in the scenario of animal 
production. George et al. offers an extended review on chemical 
control of ticks that can be consulted for further information10.
Recent studies in Brazil and Mexico showed that the 
resistance to drugs such as cipermetrine and amitraz in 
Rhipicephalus microplus, and other ticks, is increasing13,16-18. 
The speed, with which resistance has appeared, along with 
the signifi cantly more expensive pesticides, has restrained 
the companies to develop new drugs. The introduction of a 
new product in the market is time-consuming and has a huge 
economic burden; being the cost of discovering and developing 
a novel product estimated in US$100 million, with an average 
duration of 10 years11. This and the increasing concerns about 
resistance and side effects of insecticidal compounds, has 
led to the introduction of few new products over the years 
(e.g. spinosad)12,19. 
Recently, particular attention has been focused on the 
development of entomopathogenic fungi20, such as Metarhizium 
anisopliae and Beauveria bassiana, as biocontrol agents 
against a range of several ticks under laboratory and fi eld 
conditions, namely Rhipicephalus annulatus21, Ixodes 
scapularis22, Rhipicephalus appendiculatus and Amblyomma 
variegatum23, Argas persicus24 and Ornithodoros lahorensis25. 
Biocontrol agents usually favor both human and environmental 
safety, especially in comparison to the use of acaricides, 
but few biopesticide have been used in spite of their 
potential. The inability to successfully adopt biocontrol 
strategies includes factors like environmental stability 
(e.g., UV resistance, temperature tolerance), ability to initiate 
infection at low humidity, and potential unspecifi c damage 
to non-target invertebrates24,25.
In this review the focus is on the new strategies becoming 
available for the control of ticks and associated pathogens in 
cattle. 
VACCINES
Globally, most of the vaccines available to overcome 
TBDs are attenuated or live blood-derived. In theileriosis, the 
pathogens’ life cycle involves three developmental stages: 
sporozoites, schizonts and piroplasms26. Cattle that recover from 
infection with Theileria parva or Theileria annulata are solidly 
protected against subsequent infections with homologous strains 
but can succumb to heterologous challenge. Immunization 
with simple mixtures of parasite strains results in an attenuated 
infection that produces an effective immune response27,28. The 
only commercialized T. annulata vaccine is based on attenuated 
shizonts produced in cell culture (Rak-shavac-T®, National 
Dairy Development Board, India). Cattle immunization with 
sporozoite surface antigen-1 or attenuated schizont-infected 
cells induces limited protection against homologous or 
heterologous sporozoite challenge, whereas a combination 
of recombinant and live vaccine results in survival of all 
vaccinates29. Attenuated vaccines have also been used to protect 
cattle against babesiosis and anaplasmosis, being these results 
evidence for the creation of improved immunity, by including 
sporozoite and schizont antigens in vaccines. Attenuated 
vaccines have successfully been used against babesiosis for 
example in Argentina, Israel and Australia. Moreover, Australian 
Babesia bovis and Babesia bigemina attenuated strains are being 
used to immunize cattle in other regions of the world namely, 
Africa South America and South-East Asia as described in 
Offi ce of Environmental Information (OEI) report30. Though 
these vaccines can be effective, little is known about their full 
mechanism of action. They comprise important drawbacks, as a 
short shelf life, the potential transmission of other pathogens and 
the possible reversion to virulence, requiring a cold chain system 
of maintenance. Therefore, an additional research is needed for 
the development of safer alternatives, more cost-effective and 
better defi ned live, or subunit, vaccines. Nonetheless, alternative 
approaches have been raised to control TBDs, which involve 
the development of anti-tick vaccines that can quell both vector 
and pathogens8,31.
Recombinant vaccines became commercially available in 
the early 1990s, aiming to reduce the use of acaricides and their 
consequences. The feasibility of controlling tick infestations 
through immunization of hosts with selected tick antigens was 
achieved developing vaccines that reduced infestations on 
cattle. Vaccines against ticks allowing the inclusion of multiple 
antigens that could target a broad range of tick species and could 
also prevent transmission of pathogens32.
Tick antigens are usually regarded as either exposed or 
concealed antigens. Exposed antigens are those that naturally 
come into contact with the host immune system during tick 
infestation. Hosts immunized with these antigens are boosted 
by continuous tick exposure. Concealed antigens are not 
exposed to the host immune system and therefore repeated 
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immunizations are required to maintain high antibody titers. 
However, concealed antigens are more advantageous once ticks 
are unlikely to have evolved a mechanism to counteract the host 
immune response, contrarily to an exposed antigen32,33.
A great handicap in the development of anti-tick vaccines, 
like other anti-parasite vaccines, is the identifi cation of effective 
antigens. One of the major constraints when working with 
obligate intracellular parasites is a large excess of proteins 
of host or vector origin that interfere with pathogen protein 
detection. Among the important characteristics for a concealed 
antigen is the accessibility to antibody ingested during tick 
feeding and a vital physiological function of the tick32. The 
advances in characterization of tick genomes, along with the 
use of bioinformatics, ribonucleic acid interference (RNAi), 
mutagenesis, immunomapping, transcriptomics, proteomics, 
expression library immunization (ELI) and other technologies 
has allowed a rapid, systematic and comprehensive approach 
to tick vaccine discovery32. 
An effective antigen against ticks is the protein Bm86, 
specifically directed against the cattle tick Rhipicephalus 
microplus, it stands as the basis of two commercial vaccines, 
TickGARD Plus and Gavac Plus. The greatest effect was the 
reduction of larval infestations in subsequent generations, by 
reducing the number of engorging female ticks, their weight, 
and reproductive capacity19,31,34,35. 
Pipano et al. tested the effi cacy of a Bm86 vaccine in 
protection against ticks and pathogens transmitted by those 
ectoparasites (B. bovis and B. bigemina)36. The results showed 
that immunized cattle, when challenged with B. bovis-infected 
ticks, continued to become infected, but in the case of 
B. bigemina, Bm86-immunized animals remained protected 
against infection36. Canales et al. have cloned ortholog genes 
(Ba86 and Bm86) from R. annulatus and R. microplus, 
respectively37. Cattle vaccination with Bm86 reduced the 
R. annulatus and R. microplus numbers, weight, oviposition and 
eggs’ fertility. For Rhipicephalus decoloratus, Odongo et al., 
using a Bm86 based-vaccine, found a reduction on engorged 
adult female ticks, ticks weight and eggs weight38. Bastos, et 
al. studied the Bm86 silencing on the ability of R. microplus 
ticks to feed in B. bovis infected cattle, showing that this 
procedure decreased survival engorged ticks rate and eggs 
weight39.
Rhipicephalus microplus Bm86/Bm95 antigens have 
proven their effi cacy for the control of cattle tick infestations 
and transmission of tick-borne pathogens but only in some 
regions. In fact, the 900 tick species that have been documented 
are distributed by several geographic areas and animals are, 
therefore exposed to different tick stocks40,41. Several approaches 
have been made, like double vaccination with different active-
principles and/or several doses along the time42,43, and it became 
clear that for every region and tick species, should be formulated 
a different immunization procedure. Nonetheless, this approach 
is highly expensive and technically challenging9,31.
Some examples of research studies aiming the identifi cation 
of new vaccines are here described. The protein 64P from 
R. appendiculatus was found to be involved in ticks attachment 
and feeding, and was used to immunize guinea pigs, reducing 
nymph and adult infestation44. First studies on yolk pro-Cathepsin 
expressed in eggs of R. microplus suggested this aspartic proteinase 
as a promising antigen, however, when expressed as a recombinant 
protein in Escherichia coli and tested in a cattle trial, the effi cacy 
was merely 25%45. Another example concerns to 5’-nucleotidase 
that when tested in sheep showed positive results, but no effect 
in a subsequent trial in cattle36. The gut-expressed iron storage 
protein, ferritin 2, is another antigen that has been evaluated in 
cattle trials. Silencing of ferritin 2 by RNA interference showed 
significant impacts on tick feeding, oviposition and larval 
hatch, indicating ferritin 2 as a candidate tick vaccine antigen46.
Subolesin, fi rst discovered in I. scapularis, is a highly 
conserved protein involved in modulation of tick feeding 
and reproduction, and had a protective effect against all tick 
developmental stages when used in recombinant protein 
immunization. Subolesin was silenced by de la Fuente et al. 
through RNAi in D. variabilis, leading to degeneration of 
several tick tissues, such as guts, salivary glands, reproductive 
tissues and embryos32. Therefore, production of sterile ticks 
was made possible through subolesin knockdown by RNAi. 
Consequently, the release of subolesin-silenced ticks, as 
a sterile acarine technique (SAT), for autocidal control of 
tick populations has been proposed43. By releasing enough 
numbers of sterile individuals that mate with wild ones, it is 
expected a decrease in the wild population overtime, due to 
the lowering of the reproductive potential48. The use of sterile 
insect technique has proved its utility in dealing with crop pests, 
but its potential in tick control has not yet been explored in a 
larger scale. Kocan et al. showed that subolesin knockdown 
in I. scapularis, Dermacentor variabilis and Amblyomma 
americanum also affected oviposition, eggs embryogenesis, 
larval hatching and fertility47. Vaccination with subolesin 
reduced R. microplus survival and reproduction rates and 
tick infection by Anaplasma spp. and Babesia spp.41. Their 
results demonstrated that R. microplus infestations where 
successfully controlled by combining vaccination and release 
of transgenic ticks, which suggests that the combination of 
methods increases the effi cacy of cattle tick control, at least 
under some circumstances. Further studies are being developed 
concerning cattle vaccination in different regions of the world, 
to determine whether the promising results obtained in Mexico 
can be reproduced elsewhere8,9,42.
Looking for new antigens, Antunes et al. have characterized 
R. annulatus genes differentially expressed in response to 
B. bigemina infection using suppression-subtractive hybridisation 
(SSH) and real-time reverse transcription polymerase chain 
reaction (RT-PCR). Genes confi rmed as differentially expressed 
in infected ticks [tick receptor for OspA (TROSPA), calreticulin, 
ricinusin, serum amyloid A and Kunitz-type protease inhibitor 
(KTPI)] were functionally characterized using RNAi approach to 
analyze their role during pathogen infection in the tick vector49.
Pal et al. had already described TROSPA in I. scapularis, 
studying the effect of anti-TROSPA antibodies and gene 
knockdown during a B. burgdorferi infection. Reduced 
B. burgdorferi adherence to the I. scapularis gut was observed 
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in vivo, culminating in a defi cient colonization of the vector, 
with subsequent levels reduction of pathogens transmission to 
the mammalian host50. Antunes et al. found a similar protein 
over-expressed in B. bigemina-infected R. annulatus, with high 
sequence identity to Ixodes spp. After TROSPA knockdown, 
significant decrease in infection was observed for both 
R. annulatus and R. microplus. These results suggested the 
possibility that B. bigemina uses a TROSPA ortholog receptor 
for infection of Rhipicephalus tick cells and encouraged 
research for the characterization of this molecule in Babesia-tick 
interactions and development of transmission blocking vaccines. 
Serum amyloid A is known for being involved in host response 
to tissue injury and inflammation. After gene knockdown 
in both Rhipicephalus spp. lower infections were observed 
without weight losses, suggesting that this protein may be part 
of tick response to the stress produced by Babesia sp. infection, 
but at the same time necessary for pathogen multiplication in 
Rhipicephalus spp. ticks49. Calreticulin, already described in 
tick’s saliva by Jaworski et al. and Ferreira et al., seems to take 
a role during tick feeding, once gene knockdown resulted in a 
weight decrease of R. annulatus51,52. These results also suggest 
that this protein may be required for B. bigemina infection. 
Gene knockdown of ricinusin did not affect pathogen infection, 
thus suggesting that this molecule is not essential to control 
B. bigemina infection in Rhipicephalus spp. ticks49. 
The absence of full tick genomic data and the lack of a 
confi rmed tick RNAi pathway can underestimate the off-target 
effects in current tick RNAi experiments53. Despite this, the use 
of long dsRNAs as gene knockdown treatments in ticks has been 
accepted as a routine method for validation/support of tick gene 
function42,54,55. Some of the R. annulatus genes discovered in 
this study such as serum amyloid A, calreticulin and TROSPA 
could contribute to the development of novel vaccines designed 
to reduce tick infestations and prevent or minimize pathogen 
infection in ticks and transmission to vertebrate hosts49.
CONCLUSIONS
These revision concerns to a discussion on the methods used 
for tick and tick-borne parasites control and was mainly focused 
on the development of new recombinant vaccines.
Research in the post-genomic era is leading to the 
development of new control measures such as the recombinant 
vaccines. Despite these advances the establishment of non-living 
vaccines has been challenging. As a result, and despite several 
disadvantages, attenuated vaccines are still being used, adapted 
to conditions of each region.
After more than a decade, the two commercial tick 
recombinant vaccines are still being used in some countries such 
as Cuba, Australia and Mexico, though not worldwide due to 
commercial and technical constrains. These vaccines, however, 
when used in fi eld trials, showed very positive results on tick 
and tick-borne diseases (TBD) reduction, improving cattle 
production and reducing dependency on acaricides. In parallel, 
they also showed to be a cost-effective and environmentally safe 
strategy, to tick control.
Tick infestation is rarely a one-species issue, and therefore, 
anti-tick vaccines should aim at a more global protection 
against the main species of economical and epidemiological 
interest. The great rise of acaricide resistance, still asks for 
the implementation of an effective vaccine. The discovery 
of potential antigens against tick and tick-pathogens proteins 
should result in improved vaccines, more advantageous in an 
overall approach to control TBDs.
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